# XEPI
> **NDA208945** · New Drug Application · Sponsor: LNHC · Approved 2017-12-11
## Drug
- **FDA Application Number:** NDA208945
- **Application type:** New Drug Application
- **Brand name:** XEPI
- **Generic name:** Ozenoxacin
- **Active ingredients:** OZENOXACIN
- **Dosage form:** CREAM
- **Route:** TOPICAL
- **Marketing status:** Discontinued
- **Sponsor:** LNHC
- **First approval:** 2017-12-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208945)
---
*AI Analytics · CC0 1.0*